2. Reported outcomes.
| Study ID | All cause mortality | Major respiratory complications | Length of hospital stay, days | Cardiovascular complications | Other postop complications | Adverse effects of intervention | Comments |
| Bohner 2002 | 0/105; 5/99 | Pneumonia: 5/105; 2/99 Severe hypoxia: 17/105; 5/99 Intubation: 5/105; 1/99 |
11.8 ± 18.6; 9.5 ± 6.8 | Cardiac arrest: 2/105; 1/99 |
Delirium: 12/105; 6/99 Renal failure: 3/105; 3/99 |
Nose ulcers: 0/105; 4/99 |
ICU admission: 14/105; 6/99 |
|
Carlsson 1981 |
‐ | Atelectasis (24 hours): 10/11; 10/13 |
‐ | ‐ | ‐ | ‐ | ‐ |
| Christensen 1991 | ‐ | Atelectasis: 9/17; 11/17 Pneumonia: 5/17; 6/17 Intubation: 0/17; 1/17 |
10.4 ± 1.9/ 16.4 ± 3.2 |
‐ | 0/17; 0/17 | ‐ | Converted 95% CI into SD: Mean 10.4; 95% CI 4 to 26; 26 to 10.4 = 15.6 95% CI implies z = 1.96 Error = z (SE) 15.6= 1.96 (SE) 8.0 = SE SE = SD/SQRT (N) 8.0 = SD/SQRT (17) 1.9 = SD |
|
Denehy 2001 |
1 death (no group) |
Postop pulmonary complications: 4/18; 3/32 |
12.3 ± 4.8; 12.0 ± 4.5 |
‐ | ‐ | ‐ | ‐ |
| Gaszynski 2007 | 0/9; 0/11 | Intubation: 0 /9; 0/11 |
‐ | ‐ | ‐ | ‐ | ‐ |
| Lindner 1987 | ‐ | Atelectasis: 4/17; 0/17 Consolidation: 1/17; 1/17 Intubation: 0/17; 0/17 |
‐ | ‐ | ‐ | ‐ | ‐ |
|
Lotz 1984 |
‐ | Respiratory complications (?atelectasis): 6/16; 3/16 | ‐ | ‐ | ‐ | ‐ | ‐ |
|
Ricksten 1986 |
‐ | Atelectasis: 6/15; 1/28 |
‐ | ‐ | ‐ | ‐ | ‐ |
| Squadrone 2005 | 3/104; 0/105 |
Pneumonia: 10/104; 2/105 |
17 ± 15; 15 ± 13 | ‐ | Infection: 11/104; 3/105 Sepsis: 9/104; 2/105 |
‐ | ‐ |
| Stock 1985 | ‐ | Atelectasis: 17/42; 5/23 |
‐ | ‐ | ‐ | ‐ | ‐ |